Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4274 is a small, non-coding RNA molecule (microRNA) implicated in the post-transcriptional regulation of gene expression by binding complementary sequences in target messenger RNAs, resulting in their degradation or translational repression. It is encoded within the second intron of the SORCS2 gene and shown to regulate LAMA4, which encodes an alpha-4 laminin chain associated with cell migration and the malignant phenotype in basal-like breast cancer. Expression and regulatory effects of miR-4274 are observed in the nervous system and kidneys, though its broad biological and disease roles remain understudied. While miR-4274 is an active participant in gene regulatory networks, it is not traditionally categorized as a therapeutic target, but modulation of its activity may carry relevance as a biomarker or for future RNA-targeting strategies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4274 (miR-4274).